Acadian Asset Management
EDIT icon

Acadian Asset Management’s Editas Medicine EDIT Stock Holding History

Acadian Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Sell
1,039,001
-418,714
-29% -$1.22M ﹤0.01% 914
2026
Q1 		$3.6M Buy
1,457,715
+657,868
+82% +$1.39M 0.01% 790
2025
Q4 		$1.64M Buy
799,847
+443,189
+124% +$1.28M ﹤0.01% 968
2025
Q3 		$1.24M Sell
356,658
-35,510
-9% -$99.1K ﹤0.01% 1006
2025
Q2 		$861K Sell
392,168
-359,994
-48% -$589K ﹤0.01% 1012
2025
Q1 		$869K Buy
752,162
+558,567
+289% +$822K ﹤0.01% 965
2024
Q4 		$244K Buy
+193,595
New +$493K ﹤0.01% 1225

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Acadian Asset Management's EDIT Position: Q2 2026 in Review

Acadian Asset Management reduced its Editas Medicine (EDIT) stake by 29% in Q2 2026, selling an estimated $1.22M and leaving 1,039,001 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Acadian Asset Management first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.6M in Q1 2026. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Acadian Asset Management held 1,039,001 shares of Editas Medicine worth $3.36M as of Q2 2026.
  • Acadian Asset Management sold 418,714 Editas Medicine shares in Q2 2026, an estimated $1.22M.
  • Editas Medicine made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #914 holding.
  • Acadian Asset Management first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • Acadian Asset Management's Editas Medicine position peaked at $3.6M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.